{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:59:30Z","timestamp":1789779570768,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"KAKENHI","award":["25460099"],"award-info":[{"award-number":["25460099"]}]},{"name":"KAKENHI","award":["26293020"],"award-info":[{"award-number":["26293020"]}]},{"name":"KAKENHI","award":["26670122"],"award-info":[{"award-number":["26670122"]}]},{"name":"Neuropsychiatry Drug Discovery Consortium"},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbr.2015.04.022","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T06:32:45Z","timestamp":1429511565000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model"],"prefix":"10.1016","volume":"289","author":[{"given":"Yuta","family":"Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Katashiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuki","family":"Taruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Higashino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.04.022_bib0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic, epigenetic and environmental clues","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2015.04.022_bib0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.conb.2007.01.009","article-title":"Autism spectrum disorders: developmental disconnection syndromes","volume":"17","author":"Geschwind","year":"2007","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.bbr.2015.04.022_bib0240","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/mp.2013.102","article-title":"De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder","volume":"18","author":"Hamilton","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2015.04.022_bib0245","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ajmg.b.30655","article-title":"A DRD1 haplotype is associated with risk for autism spectrum disorders in male-only affected sib-pair families","volume":"147B","author":"Hettinger","year":"2008","journal-title":"Am J Med Genet B: Neuropsychiatr Genet"},{"key":"10.1016\/j.bbr.2015.04.022_bib0250","first-page":"15","article-title":"Association between DRD4 genotype and autistic symptoms in DSM-IV ADHD","volume":"20","author":"Reiersen","year":"2011","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.bbr.2015.04.022_bib0255","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10803-011-1312-z","article-title":"Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD)","volume":"42","author":"Staal","year":"2012","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.bbr.2015.04.022_bib0260","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/gbb.12062","article-title":"Genetic variation in dopamine-related gene expression influences motor skill learning in mice","volume":"12","author":"Qian","year":"2013","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.bbr.2015.04.022_bib0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuint.2014.01.002","article-title":"Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD)","volume":"66","author":"Nguyen","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2015.04.022_bib0270","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archgenpsychiatry.2009.137","article-title":"Brain serotonin and dopamine transporter bindings in adults with high-functioning autism","volume":"67","author":"Nakamura","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2015.04.022_bib0275","first-page":"712758","article-title":"What we have learned about autism spectrum disorder from valproic acid","author":"Chomiak","year":"2013","journal-title":"Patholog Res Int"},{"key":"10.1016\/j.bbr.2015.04.022_bib0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism \u2013 a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.bbr.2015.04.022_bib0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0290","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate","volume":"36","author":"Wagner","year":"2006","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.bbr.2015.04.022_bib0295","first-page":"576","article-title":"Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.bbr.2015.04.022_bib0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2007.11.043","article-title":"Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism","volume":"1193","author":"Nakasato","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.04.022_bib0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bbr.2015.04.022_bib0310","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2015.04.022_bib0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pbb.2014.08.013","article-title":"Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism","volume":"126","author":"Takuma","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2015.04.022_bib0320","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuropharm.2008.05.032","article-title":"A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"55","author":"Kawasaki","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0325","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.neuropharm.2011.08.041","article-title":"SEA0400, a specific Na+\/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease","volume":"61","author":"Ago","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","article-title":"Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice","volume":"114","author":"Koda","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2015.04.022_bib0335","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/npp.2013.52","article-title":"Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice","volume":"38","author":"Ago","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2013.06.026","article-title":"Synergistic effect of 5-HT1A and \u03c31 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency","volume":"75","author":"Hiramatsu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0345","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2013.10.017","article-title":"Isolation rearing reduces mechanical allodynia in a mouse model of chronic inflammatory pain","volume":"113","author":"Horiguchi","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2015.04.022_bib0350","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","article-title":"Downregulating the canonical Wnt\/\u03b2-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bbr.2015.04.022_bib0355","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mcn.2014.01.007","article-title":"Increased BDNF expression in fetal brain in the valproic acid model of autism","volume":"59","author":"Almeida","year":"2014","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bbr.2015.04.022_bib0360","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fnbeh.2014.00219","article-title":"Activation of mGluR2\/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism","volume":"8","author":"Chen","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.bbr.2015.04.022_bib0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2009.08.084","article-title":"Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat","volume":"1300","author":"Hall","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2015.04.022_bib0370","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1254\/jphs.12025SC","article-title":"Effect of prenatal valproic acid exposure on cortical morphology in female mice","volume":"118","author":"Hara","year":"2012","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bbr.2015.04.022_bib0375","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuropharm.2006.06.001","article-title":"Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice","volume":"51","author":"Ago","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0380","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/syn.20575","article-title":"Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity","volume":"63","author":"Ago","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2015.04.022_bib0385","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2295-3","article-title":"Activation of metabotropic glutamate 2\/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2015.04.022_bib0390","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.neuropharm.2011.10.004","article-title":"Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release","volume":"62","author":"Ago","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.04.022_bib0395","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2015.04.022_bib0400","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1017\/S1461145712001216","article-title":"Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism","volume":"16","author":"Banerjee","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2015.04.022_bib0405","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1017\/S1461145713000473","article-title":"5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model","volume":"16","author":"Wang","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2015.04.022_bib0445","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","article-title":"FMRP acts as a key messenger for dopamine modulation in the forebrain","volume":"59","author":"Wang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2015.04.022_bib0450","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00008877-200409000-00018","article-title":"Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex","volume":"15","author":"Ventura","year":"2004","journal-title":"Behav Pharmacol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T13:44:39Z","timestamp":1717854279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":38,"alternative-id":["S0166432815002648"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.04.022","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}